Profile
| Metric | Value |
|---|---|
| Full Name | Prestige Consumer Healthcare Inc. |
| Ticker | NYSE: PBH |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | prestigebrands.com |
| Employees | 600 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $62.76 | |
| Price, 1D Change | +0.46% | |
| Market Cap | $3B | |
| - | ||
| PE Ratio | 15.57 | |
| Beta | 0.47 | |
| Revenue | $1B | |
| Revenue, 1Y Change | +1.10% | |
| EPS | $4.29 | |
| EPS, 1Y Change | +2.72% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $4.29 | |
| EPS Estimate | N/A | $4.55 |
| EPS Est. Change | N/A | +6.15% |
| Revenue | $1.14B | |
| Revenue Estimate | N/A | $1.11B |
| Revenue Est. Change | N/A | -2.68% |
| Current Price | $62.76 | |
| Price Target | - | $78.50 |
| Price Tgt. Change | - | +25.08% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.33 | $4.17 | -3.65% | |
| $4.51 | $4.29 | -4.88% | |
| $4.55 | N/A | +6.15% | |
| $4.84 | N/A | +12.83% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $1.14B | $1.13B | -0.91% | |
| $1.13B | $1.14B | +0.61% | |
| $1.11B | N/A | -2.68% | |
| $1.14B | N/A | -0.15% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -15.78% | |
| Price, 3Y | -5.54% | |
| Market Cap, 1Y | -18.32% | |
| Market Cap, 3Y | -8.59% | |
| Revenue, 1Y | +1.10% | |
| Revenue, 3Y | +4.69% | |
| EPS, 1Y | +2.72% | |
| EPS, 3Y | +6.08% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $62.76 | |
| SMA 200 | $71.71 | |
| SMA 200 vs Price | +14.26% | |
| SMA 50 | $60.83 | |
| SMA 50 vs Price | -3.08% | |
| Beta | 0.47 | |
| ATR | $1.45 | |
| 14-Day RSI | 56.66 | |
| 10-Day Volatility | 21.02% | |
| 1-Year Volatility | 28.68% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| Dividends Paid | $0.00 | |
| Payout Ratio | 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $1.14B | |
| EPS | $4.29 | |
| Gross Profit | $634.46M | |
| Gross Margin | 55.76% | |
| Operating Profit | $349.24M | |
| Operating Margin | 30.70% | |
| Net Income | $214.61M | |
| Net Margin | 18.86% | |
| EBITDA | $361.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.54 | |
| Current Ratio | 4.20 | |
| Quick Ratio | 2.82 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 2.51 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 15.57 | |
| PS Ratio | 2.72 | |
| PB Ratio | 1.65 | |
| EV/EBITDA | 10.54 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $1.83B | |
| Cash & Equivalents | $97.88M | |
| Total Assets | $3.46B | |
| Current Assets | $448.33M | |
| Total Liabilities | $1.62B | |
| Current Liabilities | $106.62M | |
| Total Debt | $1.04B | |
| Short Term Debt | $8.54M | |
| Accounts Payable | $18.93M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $788.52M | |
| Operating Expenses | $285.22M | |
| Cost Of Goods Sold | $503.30M | |
| SG&A | $263.93M | |
| D&A | $30.17M | |
| Interest Expense | $0.00 | |
| Income Tax | $69.58M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $251.52M | |
| CFI | -$17.45M | |
| CFF | -$182.08M | |
| Capex | $8.22M | |
| Free Cash Flow | $243.29M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | → | |
| Jefferies | → | |
| Oppenheimer | → | |
| Canaccord Genuity | → | |
| RBC Capital | → | |
| Oppenheimer | → | |
| DA Davidson | → | |
| Canaccord Genuity | → | |
| DA Davidson | → | |
| DA Davidson | → |
Analyst sentiment
Institutional ownership
Screeners with PBH
Data Sources & References
- PBH Official Website www.prestigebrands.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1295947/000129594725000039/0001295947-25-000039-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1295947/000129594725000017/0001295947-25-000017-index.htm
- PBH Profile on Yahoo Finance finance.yahoo.com/quote/PBH
- PBH Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/pbh
FAQ
What is the ticker symbol for Prestige Consumer Healthcare Inc.?
The ticker symbol for Prestige Consumer Healthcare Inc. is NYSE:PBH
Does Prestige Consumer Healthcare Inc. pay dividends?
No, Prestige Consumer Healthcare Inc. does not pay dividends
What sector is Prestige Consumer Healthcare Inc. in?
Prestige Consumer Healthcare Inc. is in the Healthcare sector
What industry is Prestige Consumer Healthcare Inc. in?
Prestige Consumer Healthcare Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Prestige Consumer Healthcare Inc. based in?
Prestige Consumer Healthcare Inc. is headquartered in United States
When did Prestige Consumer Healthcare Inc. go public?
Prestige Consumer Healthcare Inc. initial public offering (IPO) was on February 10, 2005
Is Prestige Consumer Healthcare Inc. in the S&P 500?
No, Prestige Consumer Healthcare Inc. is not included in the S&P 500 index
Is Prestige Consumer Healthcare Inc. in the NASDAQ 100?
No, Prestige Consumer Healthcare Inc. is not included in the NASDAQ 100 index
Is Prestige Consumer Healthcare Inc. in the Dow Jones?
No, Prestige Consumer Healthcare Inc. is not included in the Dow Jones index
When was Prestige Consumer Healthcare Inc. last earnings report?
Prestige Consumer Healthcare Inc.'s most recent earnings report was on November 6, 2025
When does Prestige Consumer Healthcare Inc. report earnings?
The next expected earnings date for Prestige Consumer Healthcare Inc. is February 5, 2026
